|
Synonyms: ALN-81890 | BRII-835 | VIR-2218
Compound class:
Nucleic acid
Comment: Elebsiran (VIR-2218) is a N-acetylgalactosamine (GalNAc)-conjugated small interfering RNA (siRNA) that is designed to target hepatitis B virus (HBV) RNA as a mechanism to combat chronic HBV infection [2]. The nucleotides are chemically modified (2'-O-methyl/2'-MOE and 2'-deoxy-2'-fluoro/2'-F monomers), with a mixed phosphorothioate/phosphate backbone.
|
Classification ![]() |
|
| Compound class | Nucleic acid |
| Compound subclass | siRNA |
| Target | hepatitis B virus RNA |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12341 | elebsiran |
Synonyms ![]() |
| ALN-81890 | BRII-835 | VIR-2218 |
Database Links ![]() |
|
| CAS Registry No. | 2648009-64-5 (source: WHO INN record) |
| DrugBank Ligand | DB19018 |
| Search PubMed clinical trials | elebsiran |
| Search PubMed titles | elebsiran |
| Search PubMed titles/abstracts | elebsiran |